A researcher prepares a sample at BeiGene's research and development centre in Beijing on May 24, 2018. The company is opening a facility in Guangzhou late this year specifically built for large molecule biological drugs. Photo: Bloomberg

Topic |   Pharmaceuticals
A researcher prepares a sample at BeiGene's research and development centre in Beijing on May 24, 2018. The company is opening a facility in Guangzhou late this year specifically built for large molecule biological drugs. Photo: Bloomberg
READ FULL ARTICLE